Simcere Pharmaceutical Co., Ltd
Clinical trials sponsored by Simcere Pharmaceutical Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a simple tablet protect your brain after a stroke? Results expected Dec 2026 (estimated)
- New asthma drug aims to cut severe attacks in half Results expected Feb 2027 (estimated)
- New RSV drug for babies shows promise in phase 3 trial Results expected Mar 2027 (estimated)
-
New drug shows promise for lupus kidney disease in early trial
Disease control Not yet recruitingThis study tests a new drug, SIM0278, in 60 adults with active lupus nephritis, a kidney disease caused by lupus. Participants will receive either SIM0278 or a placebo, and researchers will check if the drug helps improve kidney function over 52 weeks. The goal is to see if SIM02…
Phase 2 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Healthy volunteers test new remdesivir formulation for better absorption
Knowledge-focused Not yet recruitingThis study tests two different versions of a deuterated remdesivir oral suspension in 48 healthy Chinese adults to see how well each is absorbed. Participants will receive both forms in a random order. The goal is to find out if the new formulation works as well as the original, …
Phase 1 • Sponsor: Simcere Pharmaceutical Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC